Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized colistin vs nebulized tobramycin + fosfomycin for ventilator-associated pneumonia due to multidrug-resistant Acinetobacter
IRCT20171230038142N11Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of colistin, tobramycin and fosfomycin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Aug 2019; status: completed.
02
Drugs
colistintobramycinfosfomycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20171230038142N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171230038142N11.